GlassScriptPhysician profile
David M Wolfsohn
NPI 1073653705
$3,856.51
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,354 · 2020: $489 · 2021: $744 · 2022: $1,270.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $938.55 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $748.84 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $705.55 | 2019-2022 | |
| Gilead Sciences, INC. | $323.43 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $170.85 | 2019-2022 | |
| Celgene Corporation | $149.66 | 2022 | |
| Janssen Biotech, INC. | $145.57 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $143.36 | 2019-2020 | |
| Ucb, INC. | $134.25 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $103.25 | 2019-2022 | |
| Qol Medical, LLC | $68.96 | 2021 | |
| Allergan, INC. | $51.48 | 2019 | |
| Alfasigma USA, INC. | $36.49 | 2020 | |
| Genzyme Corporation | $28.27 | 2022 | |
| Endo Pharmaceuticals INC. | $26.06 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $22.58 | 2021 | |
| Daiichi Sankyo INC. | $16.06 | 2019 | |
| Shire North American Group INC | $15.93 | 2019 | |
| Braintree Laboratories, INC. | $14.41 | 2022 | |
| Redhill Biopharma INC. | $12.96 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wolfsohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.